The first 9 Meters Biopharma trade was made in Q2 2020.
Since then Jim Simons bought shares six more times and sold shares on six occasions. The investor sold all their shares in Q3 2023 and doesn't own any shares in 9 Meters Biopharma anymore.
Avg closing price
Price range
Sold -15.2k shares
Q3 2023
Avg closing price
$0.47
Price range
$0.07
-
$0.68
Increased shares by 6.0% (+855 shares)
Q2 2023
Avg closing price
$0.88
Price range
$0.65
-
$1.37
Sold 80.4% shares (-58.8k shares)
Q1 2023
Avg closing price
$1.89
Price range
$1.31
-
$2.61
Sold 12.0% shares (-9.94k shares)
Q4 2022
Avg closing price
$2.28
Price range
$1.00
-
$4.70
Increased shares by 254.2% (+59.6k shares)
Q3 2022
Avg closing price
$4.96
Price range
$4.14
-
$6.30
Sold 79.1% shares (-88.9k shares)
Q2 2022
Avg closing price
$9.42
Price range
$5.22
-
$12.82
New holding (+112k shares)
Q1 2022
Avg closing price
$13.66
Price range
$10.44
-
$20.00
Sold -65.3k shares
Q3 2021
Avg closing price
$23.57
Price range
$20.60
-
$28.20
New holding (+65.3k shares)
Q2 2021
Avg closing price
$24.55
Price range
$20.80
-
$30.00
Sold -31.5k shares
Q1 2021
Avg closing price
$30.73
Price range
$16.78
-
$43.20
Increased shares by 86.5% (+14.6k shares)
Q4 2020
Avg closing price
$16.68
Price range
$12.97
-
$22.20
Increased shares by 162.2% (+10.4k shares)
Q3 2020